Home Quantitative Automated Particle-Enhanced Immunonephelometric Assay for the Routinary Measurement of Human Cystatin C
Article
Licensed
Unlicensed Requires Authentication

Quantitative Automated Particle-Enhanced Immunonephelometric Assay for the Routinary Measurement of Human Cystatin C

  • Michele Mussap , Nicoletta Ruzzante , Mariacristina Varagnolo and Mario Plebani
Published/Copyright: June 1, 2005
Become an author with De Gruyter Brill
Clinical Chemistry and Laboratory Medicine (CCLM)
From the journal Volume 36 Issue 11

Abstract

Human cystatin C is a low molecular mass protein of 13359 Dalton recently proposed as a new very sensitive marker of changes in glomerular filtration rate. Serum cystatin C concentration correlates negatively with glomerular filtration rate as well as or better than creatinine. We evaluated a recently introduced automated nephelometric immunoassay for cystatin C in serum or EDTA-plasma samples on the Behring Nephelometer System. The assay consists of incubating the 100-fold diluted sample for 6 minutes with latex particles covalently coated with anti-human cystatin C antibodies, and then quantifying the change of light-scatter produced. Method reproducibility is satisfactory, the intra-and inter-assay coefficients of variation ranging from 1.58 % to 3.77 % and from 5.6 % to 11.47 % respectively. Rheumatoid factor (≤ 1116 IU/ml), bilirubin (≤ 418 μmmol/l), triglycerides (10.47 mmol/l), and haemoglobin (12 g/l) do not significantly interfere in the assay. No significant difference was found in cystatin C concentration between serum and EDTA-plasma samples. Cystatin C is stable in serum samples stored under different conditions up to one month. This method correlates well (mean difference = −0.536 ± 0.307 mg/l) with another commercially available particle-enhanced turbidimetric immunoassay. Cystatin C offers better clinical sensitivity than creatinine for discriminating patients with normal renal function and those with mild-to-moderate reduction in renal function. This method is suitable for routine cystatin C measurement, including emergencies.

:
Published Online: 2005-06-01
Published in Print: 1998-11-01

Walter de Gruyter GmbH & Co. KG

Articles in the same Issue

  1. Expert Systems for the Interpretation of Serum Proteins
  2. Proteome in Perspective
  3. Usefulness of Chromogranin A as a Marker for Detection of Relapses of Carcinoid Tumours
  4. Comparison of Tissue Polypeptide Antigen (TPA) with Cancer Antigen 15-3 (CA 15-3) and Carcino-embryonic Antigen (CEA) in Follow-up of Breast Cancer
  5. Continuous Analysis in Extracorporeally Circulating Blood - A Rat Model Applying Flow-Through Ion-Selective Electrodes for the Measurement of Ca2+, K+, Na+ and pH
  6. Improved Specificity of a New Direct Assay for Urinary Cortisol: Application in Corticoid Treated Patients
  7. Quantitative Automated Particle-Enhanced Immunonephelometric Assay for the Routinary Measurement of Human Cystatin C
  8. External Quality Assessment of Stat Test Intralaboratory Turnaround Times. Pilot Study from the Members of the Working Group for the Standardization and Promotion of Turnaround Time Control under the Auspices of the Comitato Italiano per la Standardizzazione die Metodi Ematologici e di Laboratorio
  9. Biological Effects of Eleven Combined Oral Contraceptives on Serum Triglycerides, γ-Glutamyltransferase, Alkaline Phosphatase, Bilirubin and other Biochemical Variables
  10. Diagnostic and Prognostic Value of Biochemical Markers in Malignant Bone Disease: A Prospective Study on the Effect of Bisphosphonate on Pain Intensity and Progression of Malignant Bone Disease
  11. IFCC Committee on Standardization of Markers of Cardiac Damage: Premises and Project Presentation
  12. Medical Microbiology by C. Mims, J. Playfair, I. Roitt, D. Wakelin and R. Williams
  13. The Scientist as Consultant. Building New Career Opportunities by Carl J. Sindermann and Thomas K. Sawyer
Downloaded on 31.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.1998.151/html?lang=en
Scroll to top button